Author details

Full Name

Ruqi Tang

Affiliation

ORCID

Career Start Year

2004

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37505225	Itaconate inhibits CD103 + T RM cells and alleviates hepatobiliary injury in mouse models of primary sclerosing cholangitis.	Hepatology	2024
33793160	Implications of gut microbiota in autoimmune liver diseases.	Minerva Gastroenterology	2023
37845416	MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis.		2023
37659731	A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.	J Hepatol	2023
37734621	Human activities contributing to the accumulation of high-risk trace metal(loid)s in soils of China's five major urban agglomerations.		2023
38089552	Fine mapping identifies independent HLA associations in autoimmune hepatitis type 1.	JHEP Rep	2023
37348755	Differential regulation of JAK1 expression by ETS1 associated with predisposition to primary biliary cholangitis.	J Genet Genomics	2023
37155188	IL-26 modulates T cell function in autoimmune hepatitis.		2023
36584651	Spatio-temporal characteristics of soil Cd pollution and its influencing factors: A Geographically and temporally weighted regression (GTWR) method.		2023
36642058	Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells.	J Autoimmun	2023
36639314	Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581].	J Hepatol	2023
36799463	P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases.	Hepatology	2023
36977669	A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression.	Nat Commun	2023
35345553	LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment.		2022
35657576	Serum Biomarkers for Autoimmune Hepatitis Type 1: the Case for CD48 and a Review of the Literature.	Clinical Reviews in Allergy and Immunology	2022
36172356	Tissue-resident memory T cells in chronic liver diseases: Phenotype, development and function.	Frontiers in Immunology	2022
36159854	Intrahepatic activated leukocyte cell adhesion molecule induces CD6CD4 T cell infiltration in autoimmune hepatitis.	Frontiers in Immunology	2022
35753523	NUDT1 promotes the accumulation and longevity of CD103<sup>+</sup> T<sub>RM</sub> cells in primary biliary cholangitis.	J Hepatol	2022
36270718	Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis.	Clinics in Liver Disease	2022
36193976	Intestinal homeostasis in autoimmune liver diseases.	Chinese Medical Journal	2022
35720005	FOXP4-AS1 Inhibits Papillary Thyroid Carcinoma Proliferation and Migration Through the AKT Signaling Pathway.	Frontiers in Oncology	2022
36591302	The immunological characteristics of TSPAN1 expressing B cells in autoimmune hepatitis.		2022
33666868	Correction to: Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Singleâ¿¿Center Experience and Literature Review.	Clin Rev Allergy Immunol	2022
33512642	Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature Review.	Clin Rev Allergy Immunol	2022
34035120	Altered faecal microbiome and metabolome in IgG4-related sclerosing cholangitis and primary sclerosing cholangitis.	Gut	2022
35184318	Genome-wide meta-analysis identifies susceptibility loci for autoimmune hepatitis type 1.	Hepatology	2022
34894107	MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells.	Hepatol Commun	2022
34433101	Mapping of de novo mutations in primary biliary cholangitis to a disease-specific co-expression network underlying homeostasis and metabolism.	Journal of Genetics and Genomics	2022
34774091	Pressure dressings versus nonpressure dressings after hemorrhoidectomy: study protocol for a randomized controlled trial.	Trials	2021
34225426	[Expression and clinical significance of interleukin-16 in patients with primary biliary cholangitis].	Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology	2021
33928766	CD8 T cells actively penetrate hepatocytes via the CD44/p-ERM/F-actin pathway in autoimmune hepatitis.	Journal of Digestive Diseases	2021
33554350	The Clinical Significance of Hepatic CD69<sup>+</sup> CD103<sup>+</sup> CD8<sup>+</sup> Resident-Memory T Cells in Autoimmune Hepatitis.	Hepatology	2021
33318628	Gut microbiome, liver immunology, and liver diseases.	Cell Mol Immunol	2021
32712804	Interleukin-35 Promotes Th9 Cell Differentiation in IgG4-Related Disorders: Experimental Data and Review of the Literature.	Clinical Reviews in Allergy and Immunology	2021
34512667	Myeloid-Derived Suppressive Cells Deficient in Liver X Receptor Î± Protected From Autoimmune Hepatitis.	Frontiers in Immunology	2021
34437819	Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis.	Gut Microbes	2021
31201284	Alterations of gut microbiome in autoimmune hepatitis.	Gut	2020
31810856	Fine mapping of the MHC region identifies major independent variants associated with Han Chinese primary biliary cholangitis.	J Autoimmun	2020
32445099	Epigenetics of Primary Biliary Cholangitis.	Advances in Experimental Medicine and Biology	2020
30900136	Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.	Clin Rev Allergy Immunol	2020
30709684	Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?	J Autoimmun	2019
31016654	Proteomics in Primary Biliary Cholangitis.	Methods Mol Biol	2019
30854688	Genome-wide Association Studies of Specific Antinuclear Autoantibody Subphenotypes in Primary Biliary Cholangitis.	Hepatology	2019
31255417	Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis.	J Autoimmun	2019
31102333	CTHRC1 expression in primary biliary cholangitis.	J Dig Dis	2019
28213609	Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.	Gut	2018
28777871	A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.	Hepatology	2018
30233587	Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization.	Front Immunol	2018
29706647	The microbiome and autoimmunity: a paradigm from the gut-liver axis.	Cell Mol Immunol	2018
29429758	The immunobiology of mucosal-associated invariant T cell (MAIT) function in primary biliary cholangitis: Regulation by cholic acid-induced Interleukin-7.	J Autoimmun	2018